SCHEMBL6403433

SCHEMBL6403433

O=C(O)NCc1cc(-c2cccc(CN3C(=O)c4cccc(NC(=O)c5ccc(Cl)s5)c4C3=O)c2)ccc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 3/20 0.42
HDAC1 Q13547 2/20 0.41
HDAC4 P56524 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41
HDAC5 Q9UQL6 1/20 0.41
TP53 P04637 4/20 0.37
ACHE P22303 1/20 0.37
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
CHRM3 P20309 1/20 0.36
GRM5 P41594 2/20 0.36
PRSS12 P56730 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
SLC2A1 P11166 1/20 0.35
CA9 Q16790 1/20 0.35
CA12 O43570 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5784393 0.90 F10 (0.42) F10HDAC1HDAC4HDAC7HDAC8
Hydrochloric Acid SCHEMBL6403511 0.89 F10 (0.42) F10HDAC1HDAC4HDAC7HDAC8
SCHEMBL6402784 0.86 F10 (0.52) F10HDAC1HDAC4HDAC7HDAC8
SCHEMBL5784009 0.86 F10 (0.39) F10HDAC1HDAC4HDAC7HDAC8
SCHEMBL6403437 0.84 HDAC1 (0.40) F10HDAC1HDAC4HDAC7HDAC8
SCHEMBL5784005 0.83 F10 (0.38) F10HDAC1HDAC4HDAC7HDAC8
SCHEMBL5779826 0.80 F10 (0.48) F10HDAC1ACHEKDM4EMAPT
SCHEMBL5781951 0.79 F10 (0.51) F10HDAC1HDAC4HDAC7HDAC8
SCHEMBL3381035 0.79 F10 (0.51) F10HDAC1HDAC4HDAC7HDAC8
SCHEMBL5781909 0.79 F10 (0.51) F10HDAC1TP53ACHEKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6933295-B2 Substituted isoindoles and the use thereof BAYER AKTIENGESELLSCHAFT (DE) 2005-08-23 US disclosed
US-20050004207-A1 Nitrogen compounds such as N-(2-{4-[2-Amino-2-(hydroxyimino)ethyl]benzyl}-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl)-5-chloro-2-thiophenecarboxamide, used as blood-coagulation factor Xa antogonists for prophylaxis of cardiovascular disorders BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004207-A1 Nitrogen compounds such as N-(2-{4-[2-Amino-2-(hydroxyimino)ethyl]benzyl}-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl)-5-chloro-2-thiophenecarboxamide, used as blood-coagulation factor Xa antogonists for prophylaxis of cardiovascular disorders F2, SERPINC1, F11 F10 4/4885HDAC1 1191/4885HDAC4 2003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.